Northern Capital Management (Wisconsin)’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Northern Capital Management (Wisconsin)’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-99,213	Closed	-$733K	–	150
2016 Q2	$733K	Sell	99,213 -825	-0.8%	-$6.19K	0.33%	91
2016 Q1	$639K	Sell	100,038 -660	-0.7%	-$3.7K	0.28%	102
2015 Q4	$629K	Buy	100,698 +735	+0.7%	+$4.82K	0.28%	107
2015 Q3	$584K	Sell	99,963 -40,907	-29%	-$315K	0.25%	110
2015 Q2	$1.17M	Sell	140,870 -32,005	-19%	-$283K	0.54%	64
2015 Q1	$1.42M	Buy	172,875 +400	+0.2%	+$2.96K	0.68%	54
2014 Q4	$1.19M	Sell	172,475 -10,500	-6%	-$65.7K	0.58%	67
2014 Q3	$988K	Buy	182,975 +34,525	+23%	+$202K	0.5%	74
2014 Q2	$946K	Buy	148,450 +135,850	+1,078%	+$934K	0.47%	73
2014 Q1	$102K	Buy	+12,600	New	+$98.1K	0.05%	147

Other funds holding ARIA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Northern Capital Management (Wisconsin)'s ARIA Position: Q3 2016 in Review

Northern Capital Management (Wisconsin) sold out of Ariad Pharmaceuticals Inc (ARIA) in Q3 2016, closing a stake of 99,213 shares — an estimated $733K sold.

Northern Capital Management (Wisconsin) first reported a position in ARIA in Q1 2014 and held it in 10 quarters. The position peaked at $1.42M in Q1 2015. 202 funds tracked by Wall St. Rank hold ARIA as of Q3 2016.

Northern Capital Management (Wisconsin) reported no remaining Ariad Pharmaceuticals Inc position as of Q3 2016 after selling out during the quarter.
Northern Capital Management (Wisconsin) sold 99,213 Ariad Pharmaceuticals Inc shares in Q3 2016, an estimated $733K.
Northern Capital Management (Wisconsin) first reported a position in Ariad Pharmaceuticals Inc in Q1 2014 and held it in 10 quarters.
Northern Capital Management (Wisconsin)'s Ariad Pharmaceuticals Inc position peaked at $1.42M in Q1 2015.
202 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q3 2016.

Based on Northern Capital Management (Wisconsin)'s 13F filing for Q3 2016, filed 3 Nov 2016.